Clinical Trials for Mustang Bio

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Mustang Bio

Clinical Trials (2)

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

PHASE1/PHASE2Active, not recruiting

53 participants

Started: Dec 5, 2017 · Completed: Nov 16, 2037

23 conditions2 sponsors1 location

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

PHASE1Active, not recruiting

31 participants

Started: Dec 15, 2015 · Completed: Aug 6, 2026

13 conditions3 sponsors1 location